HR. 1414In Committee
Cameron’s Law
Increases the orphan drug tax credit to 50% of qualified clinical testing expenses for developing drugs that treat certain rare diseases or conditions
Plain-English overview
What this bill does
Increases the orphan drug tax credit to 50% of qualified clinical testing expenses for developing drugs that treat certain rare diseases or conditions
Key points
- Increase orphan drug tax credit
Current status
Where it stands
Status
In Committee
Latest action
2025-02-18 — Referred to the House Committee on Ways and Means.
Related context
Topics and policy areas
undefinedTaxation